British journal of pharmacology (Br J Pharmacol)

Journal PubWeight™ 20888.83‹?›

Top papers

Rank Title Year PubWeight™‹?›
1 Animal research: reporting in vivo experiments: the ARRIVE guidelines. 2010 17.30
2 Guidelines for reporting experiments involving animals: the ARRIVE guidelines. 2010 13.76
3 Guide to Receptors and Channels (GRAC), 3rd edition. 2008 13.18
4 Guide to Receptors and Channels (GRAC), 5th edition. 2011 10.40
5 The rat anococcygeus muscle and its response to nerve stimulation and to some drugs. 1972 9.97
6 Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. 1990 8.85
7 Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non-adrenergic inhibitory nerves in the gut. 1970 8.20
8 Guide to Receptors and Channels (GRAC), 4th Edition. 2009 8.07
9 Stimulus-secretion coupling: the concept and clues from chromaffin and other cells. 1968 7.91
10 The release and fate of vaso-active hormones in the circulation. 1969 7.90
11 A method of stimulating different segments of the autonomic outflow from the spinal column to various organs in the pithed cat and rat. 1970 7.77
12 L-NG-nitro arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro. 1990 7.27
13 A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. 1989 6.30
14 Resistance to -adrenoceptor stimulants (a possible explanation for the rise in ashtma deaths). 1971 6.11
15 Sixth gaddum memorial lecture, National Institute for Medical Research, Mill Hill, January 1977. Presynaptic receptors and their role in the regulation of transmitter release. 1977 6.01
16 The inhibitory action of noradrenaline and adrenaline on acetylcholine output by guinea-pig ileum longitudinal muscle strip. 1969 6.01
17 The Concise Guide to PHARMACOLOGY 2015/16: Enzymes. 2015 5.96
18 Binding, gating, affinity and efficacy: the interpretation of structure-activity relationships for agonists and of the effects of mutating receptors. 1998 5.93
19 The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors. 2013 5.74
20 The Concise Guide to PHARMACOLOGY 2013/14: enzymes. 2013 5.57
21 Experimental design and analysis and their reporting: new guidance for publication in BJP. 2015 5.43
22 Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? 2004 5.29
23 The effect of amiodarone, a new anti-anginal drug, on cardiac muscle. 1970 5.24
24 Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. 1987 5.23
25 The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. 1987 4.88
26 Comparison of the effects of BRL 34915 and verapamil on electrical and mechanical activity in rat portal vein. 1986 4.75
27 Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors. 1972 4.53
28 Suramin: a reversible P2-purinoceptor antagonist in the mouse vas deferens. 1988 4.52
29 A comparison of affinity constants for muscarine-sensitive acetylcholine receptors in guinea-pig atrial pacemaker cells at 29 degrees C and in ileum at 29 degrees C and 37 degrees C. 1976 4.50
30 Rapid method for the determination of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in small regions of rat brain. 1970 4.48
31 Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP. 2015 4.46
32 Evaluation of mechanisms controlling the release and inactivation of the adrenergic transmitter in the rabbit portal vein and vas deferens. 1972 4.45
33 Relationships between chemical structure and affinity for acetylcholine receptors. 1969 4.28
34 The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors. 2015 4.28
35 Radioactive aniline clearance from canine gastric pouches for the measurement of gastric mucosal blood flow. 1971 4.26
36 Bioassay of prostacyclin and endothelium-derived relaxing factor (EDRF) from porcine aortic endothelial cells. 1986 4.23
37 The orphan receptor GPR55 is a novel cannabinoid receptor. 2007 4.22
38 The effects of adrenaline, noradrenaline and isoprenaline on inhibitory alpha- and beta-adrenoceptors in the longitudinal muscle of the guinea-pig ileum. 1970 4.22
39 Comparison of the effects of I.C.I. 50172 and propranolol on the cardiovascular responses to adrenaline, isoprenaline and exercise. 1968 4.20
40 A new example of a morphine-sensitive neuro-effector junction: adrenergic transmission in the mouse vas deferens. 1972 4.11
41 Depolarizing actions of gamma-aminobutyric acid and related compounds on rat superior cervical ganglia in vitro. 1974 3.97
42 The role of inflammation in CNS injury and disease. 2006 3.96
43 Receptors for 5-hydroxytryptamine and noradrenaline in rabbit isolated ear artery and aorta. 1976 3.95
44 Endothelium-dependent hyperpolarization of canine coronary smooth muscle. 1988 3.88
45 Salbutamol: a new, selective beta-adrenoceptive receptor stimulant. 1969 3.86
46 Role of transmitter uptake mechanisms in synaptic neurotransmission. 1971 3.82
47 Effect of morphine on adrenergic transmission in the mouse vas deferens. Assessment of agonist and antogonist potencies of narcotic analgesics. 1975 3.76
48 The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate. 1983 3.69
49 The effects of BRL 34915 and nicorandil on electrical and mechanical activity and on 86Rb efflux in rat blood vessels. 1986 3.68
50 Acetylcholine releases endothelium-derived hyperpolarizing factor and EDRF from rat blood vessels. 1988 3.66
Next 50